BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36849730)

  • 1. Evaluating elimination thresholds and stopping criteria for interventions against the vector-borne macroparasitic disease, lymphatic filariasis, using mathematical modelling.
    Sharma S; Smith ME; Bilal S; Michael E
    Commun Biol; 2023 Feb; 6(1):225. PubMed ID: 36849730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020.
    Michael E; Singh BK; Mayala BK; Smith ME; Hampton S; Nabrzyski J
    BMC Med; 2017 Sep; 15(1):176. PubMed ID: 28950862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
    Gambhir M; Bockarie M; Tisch D; Kazura J; Remais J; Spear R; Michael E
    BMC Biol; 2010 Mar; 8():22. PubMed ID: 20236528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.
    Singh BK; Michael E
    Parasit Vectors; 2015 Oct; 8():522. PubMed ID: 26490350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.
    Michael E; Singh BK
    BMC Med; 2016 Jan; 14():14. PubMed ID: 26822124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulating a Transmission Assessment Survey: An evaluation of current methods used in determining the elimination of the neglected tropical disease, Lymphatic Filariasis.
    Weiss PS; Michael E; Richards FO
    Int J Infect Dis; 2021 Jan; 102():422-428. PubMed ID: 33130207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.
    Gambhir M; Michael E
    PLoS One; 2008 Aug; 3(8):e2874. PubMed ID: 18716676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework.
    Smith ME; Singh BK; Irvine MA; Stolk WA; Subramanian S; Hollingsworth TD; Michael E
    Epidemics; 2017 Mar; 18():16-28. PubMed ID: 28279452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination.
    Michael E; Sharma S; Smith ME; Touloupou P; Giardina F; Prada JM; Stolk WA; Hollingsworth D; de Vlas SJ
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006674. PubMed ID: 30296266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling lymphatic filariasis transmission and control: modelling frameworks, lessons learned and future directions.
    Stolk WA; Stone C; de Vlas SJ
    Adv Parasitol; 2015 Mar; 87():249-91. PubMed ID: 25765197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
    Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China.
    Fang Y; Zhang Y
    Infect Dis Poverty; 2019 Aug; 8(1):66. PubMed ID: 31387644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.
    Subramanian S; Jambulingam P; Krishnamoorthy K; Sivagnaname N; Sadanandane C; Vasuki V; Palaniswamy C; Vijayakumar B; Srividya A; Raju HKK
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007862. PubMed ID: 31978060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons Learned From Developing an Eradication Investment Case for Lymphatic Filariasis.
    Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
    Adv Parasitol; 2016; 94():393-417. PubMed ID: 27756458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
    Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
    Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subnational Projections of Lymphatic Filariasis Elimination Targets in Ethiopia to Support National Level Policy.
    Prada JM; Touloupou P; Kebede B; Giorgi E; Sime H; Smith M; Kontoroupis P; Brown P; Cano J; Farkas H; Irvine M; Reimer L; Caja Rivera R; de Vlas SJ; Michael E; Stolk WA; Pulan R; Spencer SEF; Hollingsworth TD; Seife F
    Clin Infect Dis; 2024 Apr; 78(Supplement_2):S117-S125. PubMed ID: 38662702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing endgame strategies for the elimination of lymphatic filariasis: A model-based evaluation of the impact of DEC-medicated salt.
    Smith ME; Singh BK; Michael E
    Sci Rep; 2017 Aug; 7(1):7386. PubMed ID: 28785097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.
    Stolk WA; Prada JM; Smith ME; Kontoroupis P; de Vos AS; Touloupou P; Irvine MA; Brown P; Subramanian S; Kloek M; Michael E; Hollingsworth TD; de Vlas SJ
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S260-S266. PubMed ID: 29860286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.